84 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
, subcontract, lease, license, sublicense or other legally binding commitment or undertaking.
“Contracting Party” has the meaning set forth in Section … nor any of its Subsidiaries has made any plan or commitment to create any additional Benefit Plan or modify or change any existing Benefit Plan
8-K/A
EX-99.1
dk6l3n n7
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
r6g2yr05wdsoj
27 Oct 23
Regulation FD Disclosure
4:19pm
424B3
bsu3kz1 xmacxk0mggc
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
q023ry mgyxc3t
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
ryqnjctaqj1cstq8zupn
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
kqsks4l
16 Jun 23
Business combination disclosure
8:08am
425
adhr2m2y
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
r33kvpn ywp3wnot66em
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
6t42odf6
18 May 23
Other Events
5:02pm
8-K
EX-99.1
ozvu m0trz
8 May 23
Coherus BioSciences Reports First Quarter 2023 Financial Results and Business Highlights
4:16pm